New inhibitors of BRD4 identified by combining fragment-based and HTS approaches

被引：0
|
作者：
Borysko, Petro [2 ]
Vasykhenko, Olexander [1 ]
Zozulya, Sergey [2 ]
Moroz, Yurii [1 ]
机构：
[1] Natl Taras Shevchenko Univ Kyiv, ChemBioCtr, Kiev, Ukraine
[2] Enamine Ltd, Bienta, Kiev, Ukraine
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
124
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dual HDAC/BRD4 inhibitors against cancer
    Negar Omidkhah
    Farzin Hadizadeh
    Razieh Ghodsi
    Medicinal Chemistry Research, 2021, 30 : 1822 - 1836
  • [22] Design and synthesis of dual ALK/BRD4 inhibitors
    Watts, Ellen
    Tucker, Elizabeth
    Heidenreich, David
    Bellenie, Benjamin
    Knapp, Stefan
    Chesler, Louis
    Hoelder, Swen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [23] Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis
    Zhangxu He
    Haomiao Jiao
    Qi An
    Xin Zhang
    Dan Zengyangzong
    Jiale Xu
    Hongmin Liu
    Liying Ma
    Wen Zhao
    Acta Pharmaceutica Sinica B, 2022, 12 (01) : 291 - 307
  • [24] Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis
    He, Zhangxu
    Jiao, Haomiao
    An, Qi
    Zhang, Xin
    Zengyangzong, Dan
    Xu, Jiale
    Liu, Hongmin
    Ma, Liying
    Zhao, Wen
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (01) : 291 - 307
  • [25] BRD4 degradation by PROTACs represents a more effective therapeutic strategy than BRD4 inhibitors in ovarian cancer
    Raina, Kanak
    Lu, Jing
    Qian, Yimin
    Altieri, Martha
    Dong, Hanging
    Wang, Jing
    Chen, Xin
    Crew, Andrew
    Coleman, Kevin
    Crews, Craig
    Winkler, James
    CANCER RESEARCH, 2016, 76
  • [26] Fragment-based approaches to TB drugs
    Marchetti, Chiara
    Chan, Daniel S. H.
    Coyne, Anthony G.
    Abell, Chris
    PARASITOLOGY, 2018, 145 (02) : 184 - 195
  • [27] Fragment-based approaches to enzyme inhibition
    Ciulli, Alessio
    Abell, Chris
    CURRENT OPINION IN BIOTECHNOLOGY, 2007, 18 (06) : 489 - 496
  • [28] BRD4 is a new therapeutic target in melanoma
    Fontanals-Cirera, Barbara
    Segura, Miguel F.
    Gaziel-Sovran, Avital
    Guijarro, Maria V.
    Hanniford, Doug
    Gonzalez-Gomez, Pilar
    Zhang, Weijia
    Zhang, Guantao
    Darvishian, Farbod
    Ohlmeyer, Michael
    Osman, Iman
    Zhou, Ming-Ming
    Hernando, Eva
    CANCER RESEARCH, 2013, 73
  • [29] Fragment-based identification of phosphatase inhibitors
    Rawls, Katherine
    Soellner, Matthew
    Takeuchi, Jun
    Imamura, Shinichi
    Baguley, Tyler
    Grundner, Christoph
    Alber, Tom
    Ellman, Jonathan A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [30] Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors
    Kavanagh, Madeline E.
    Coyne, Anthony G.
    McLean, Kirsty J.
    James, Guy G.
    Levy, Colin W.
    Marino, Leonardo B.
    de Carvalho, Luiz Pedro S.
    Chan, Daniel S. H.
    Hudson, Sean A.
    Surade, Sachin
    Leys, David
    Munro, Andrew W.
    Abell, Chris
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) : 3272 - 3302
12345